Ticker Scorecard - BMRN Basics Company: BioMarin Pharmaceutical Inc. IPO Date: August 1, 1999 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.87 | 1.65% Avg Daily Range (30 D): $0.74 | 1.14% Avg Daily Range (90 D): $0.67 | 1.01% Institutional Daily Volume Avg Daily Volume: 1.19M Avg Daily Volume (30 D): 1.18M Avg Daily Volume (90 D): 1.14M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 22,927 Avg Inst. Trade: $3.46M Avg Inst. Trade (30 D): $6.03M Avg Inst. Trade (90 D): $5.86M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $10.37M Avg Closing Trade (30 D): $18.62M Avg Closing Trade (90 D): $17.83M Avg Closing Volume: 125.66K     News Jan 2, 2025 @ 7:30 AM Global Mucopolysaccharidosis Treatment Market to W... Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.) Oct 14, 2024 @ 4:33 PM Hemophilia Markets Poised for Evolution as Competi... Source: Spherix Global Insights Oct 4, 2024 @ 12:44 PM 3 Oversold Stocks with Strong RSI Rebound Potentia... Source: Marketbeat.Com Sep 25, 2024 @ 7:50 PM BioMarin Stands Firm on 2027 Revenue Target Amid A... Source: Vandana Singh Sep 22, 2024 @ 9:04 PM Novo Nordisk, Chewy And FedEx Are Among Top 10 Lar... Source: Lekha Gupta Financials   TTM Q3 2024 Q2 2024 Basic EPS $1.7 $.56 $.56 Diluted EPS $1.66 $.55 $.55 Revenue $ 2.75B $ 745.74M $ 712.03M Gross Profit $ 2.19B $ 557.28M $ 581.57M Net Income / Loss $ 322.29M $ 106.08M $ 107.17M Operating Income / Loss $ 322.41M $ 113.89M $ 120.45M Cost of Revenue $ 564.82M $ 188.46M $ 130.46M Net Cash Flow $ -108.65M $ -293.8M $ 221.85M PE Ratio 37.64